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 In our study, it was aimed to determine antifungal activity of Peganum harmala on medically important 
yeasts and molds in vitro. Fungal suspensions of Candida spp and aspergillus spp isolated from the 
clinical specimens were treated with serial dilutions of P. harmala alcoholic extract in Sabouraud Broth. 
The titers included: 1/20, 1/40, 1/80, 1/160, 1/320, 1/640, and incubated for 24 h at 30°C. Anti fungal 
activity of the extract was determined as MIC and MFC. For the determination of MFC, a small volume of 
above serial dilutions was cultured on SGA 4% medium. After 24 to 72 h of incubation at 30°C, the 
cultures were looked for fungal growth. The highest and lowest inhibitory effects of P. harmala extract 
were determined on C. glabrata (MIC: 0.312 mg/ml) and C. albicans (MIC:  1.25 mg/ml), respectively. The 
MFC for Candida species was differed from 0.62 to 2.5 mg/ml. The highest fungicidal effect was seen on 
C. glabrata and C. tropicalis (MFC: 0.62 and 0.125 mg/ml, respectively) and the lowest was for C. 
albicans (MFC: 2.5 mg/ml). The treatment of Aspergillus suspensions with Perganum extract showed a 
decreasing of growth and sporolation without definite inhibition. The alcoholic extract of P. harmala 
showed a fungicidal activity on opportunistic yeasts, Candida spp, and a decreasing sporolation for 
aspergillus most importamt species. 
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INTRODUCTION 
 
Peganum harmala (Zygophyllaceae) is an intriguing herb 
with a long history of medicinal use. It is widely grow in 
the most parts of the world including North and South 
America, Mexico, Africa and Asia. P. harmala is widely 
distributed in the Southern part of Iran too. It is known as 
“espand” in Persian and is famous for its medical uses as 
analgesic and antiseptic in folk medicine. P. harmala has 
significant usages in industrial and medical aspects 
(Berrougui et al., 2006). It has been medically used by 
the people of ancient countries such as India, Iran, Egypt 
and Spain. Some people use it typically for enhancing 
limbs. People in the west Asia burn  the  seeds   to  make  
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smoke for keeping safe against voodoo (Rojhan, 2002). 
Levchenko (1987), Kang (1994) and Rashan (1989) 
carried out first studies on anti parasitic and anti viral 
activities of P. harmala. Also anti parasitic effect of the 
plant seeds have been recently reported by Iranian 
researchers (Mahdavi and Masoud, 2003; Nateghpour et 
al., 2006). Also anti tumor activity of P. harmala was 
shown by Lamchouri et al. (1999). Peganum seeds 
contain carbohydrates, lipids, proteins, minerals, amino 
acids and alcoholic compounds as well as saturated fatty 
acids.  
On the other hand, during last decades, fungi have 
emerged as new life threatening agents, considering 
increased opportunistic infections in human and animals. 
In fact, many medical centers in the world are challenge 
with the event. Furthermore some of these organisms 
have earned a resistance to anti fungal drugs. Regarding   
the    high   frequency   of  fungal  infections   among   the 
  
 
 
 
 
immunocompromised patients, and also the desirable 
effects of the P. harmala on the growth of other micro 
organisms, such as bacteria and parasites, it is 
necessary to study the antifungal usage of P. harmala 
seeds which seem to be practical. Present research is 
one of the first studies in Iran which carried out on 
antifungal activities of P. harmala in vitro. The goal was to 
measure absolute minimum concentration of alcoholic 
extract of P. harmala for inhibiting and killing of most 
important fungi causing human infection. 
 
 
MATERIALS AND METHODS 
 
Collection and identification of the plant  
 
About 2000 g of the plant seeds were prepared from traditional drug 
stores as the seeds of Espand (in Persian) and then confirmed as 
Iranian P. harmala by the Plants Systematic laboratory, UM School 
of Botany, Iran.    
 
 
Preparation of alcoholic extract 
 
Amount of 1000 g of P. harmala seeds was powdered in an 
electrical grinder and then added to 3200 ml of ethanol 96°, shaken 
for 2 h and incubated over night at room temperature to remove 
alcoholic solvent from the crude extract. Again, the same amount of 
solvent was added to the crude extract and the process was 
repeated five times. The solvent was separated completely by a 
vacuum filtering system. The final product was 110 g of a brown 
color extract with biting odor. 
 
 
Micro organisms 
 
Main subjects included 111 isolates of Candida species and 
Aspergillus species obtained from clinical specimens of patients in 
department of Medical Mycology, School of Public Health and 
Institute of Public Health Research. For the improvement of 
accuracy in the results MIC and minimum fungicidal concentration 
(MFC) tests, all of the 111 clinical isolates were used. Candida 
isolates were identified in the level of species using differential 
medium CHROM agar Candida included C. albicans, C. 
dubliniensis, C. glabrata, C. tropicalis, C. kefyre and C. parapsilosis. 
Identification of Aspergillus species by using morphological 
characteristics resulted three species of A. fumigatus, A. flavus and 
A. niger. Each fungal species was confirmed by Molecular 
Mycology laboratory of TUMS.  
 
 
Preparation of fungal suspensions 
 
Fungal suspensions including 105 Candida cells and 103 Aspergillus 
spores in aqueous Sabouraud medium were made. For avoiding 
spore propagations a little volume of Tween 80 were added into the 
suspensions. Standard Mc farland 0.5 containing barium chloride 
and sulphoric acid was used as turbidity control. 
  
 
Serial dilution of P. harmala extract 
 
Serial dilutions in tubes 
 
Small volume (1 ml) of sabouraud broth in capped tubes was used 
as substrate.  1 ml  of  10%  solution  of  the  crude  extract in sterile  
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water was added into the substrate and mixed thoroughly. Then 1 
ml of the solution was transferred into the next tube containing 1 ml 
substrate, after which it was mixed and transferred into the next 
tube with the same substrate. This was done sequentially till it got 
to the 6th tube, so that six decreasing titers of P. harmala alcoholic 
extract in substrate including:  1/20, 1/40, 1/80, 1/160, 1/320, 1/640 
were made. Then 1 ml of each Candida suspension was inoculated 
into dilution tubes and incubated at 30°C for 24 h. Negative and 
positive controls were prepared by adding 1 ml of 1/20 diluted 
extract and Candida suspension, respectively, into the substrate. 
 
 
Serial dilutions in agar media 
 
Sabouraud glucose agar 4% (SGA 4%) was measured, mixed with 
distilled water, autoclaved and dispensed in medium size (8 cm 
diameter) plates, 10 ml in each after cooling up to 60 to 55°C. While 
it was melted, the alcoholic extract was added into media plates in 
a decreasing pattern to make titers: 1/10, 1/100, 1/200, 1/400, 
1/800, respectively. After making solid agar media, 1 ml of 
Aspergillus suspensions was inoculated into the dilution plates and 
left at 30°C for 72 h.  
 
 
MIC (minimum inhibitory concentration) determination 
 
After incubation time at 30°C, the tubes and plates of reactions 
were investigated for fungal growth. It was performed for Candida 
isolates, comparing turbidity of test tubes with that of Mc Farland 
standard 0.5. Positive tubes were found without any turbidity of 
growth.  
 
 
MFC (minimum fungicidal concentration) determination 
 
All tubes without turbidity (negative for growth) in serial dilution test 
were used for the determination of MFC. A small volume from the 
negative tubes was transferred into plates of Sabouraud agar and 
the incubated at 30°C for 72 h. MFC of peganum extract on 
Candida isolates was determined finding the media plates without 
any growth of Candida colonies. For the Aspergillus isolates, the 
first dilution plate without fungal growth was considered as MFC 
point.   
 
 
RESULTS 
 
Totally 111 Candida isolates including C. albicans, C. 
parapsilosis, C. keiffir, C. glabrata tested for MIC and 
MFC. Inhibitory test on 6 Candida species and 3 
Aspergillus species resulted a range of MIC: 0.312 to 
1.25 mg/ml. Alcoholic extract of P. harmala showed; MIC: 
0.312 mg/ml on C. glabrata and MIC: 1.25 mg/ml on C. 
albicans as the highest and lowest inhibitory effects, 
respectively (Table 1). Moreover, minimum fungicidal 
concentration of the extract on Candida isolates was 
determined in a range of 0.625 to 2.5 mg/ml. 
As our results, the highest fungicidal effect of the 
extract (MFC: 0.625 mg/ml) was found on C. glabrata, 
and the lowest on C. albicans (MFC: 2.5 mg/ml). 
Our assay on Aspergilli showed different results in the 
level of species. The extract was effective on A. niger and 
A. fumigatus as growth inhibitory but for A. flavus the 
result  was  restricted   to  some  changes  in morphology  
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Table 1. MIC (minimum inhibition concentration) and MFC (minimum fungicidal concentration) in Candida species. 
 
Candida species No of isolates MIC  (mg/ml) MFC (mg/ml) 
C. albicans 102 1.25 2.5 
C. parapsilosis 11 0.625 1.25 
C. Keiffir 3 0.625 1.25 
C. glabrata 2 0.312 0.625 
C. tropicalis  2 0.312 1.25 
C. dubliensis 1 0.625 1.25 
 
 
 
 
 
Figure 1. Effect of PAE on Aspergillus fumigatus (left) and A. niger (right) in the dilution of 0.3. 
 
 
 
characteristics, macroscopic features and sporolation 
rate, color and size of colonies (Figures 1 and 2). 
Microscopic variations were not included for Aspergillus 
species. Time effectiveness in MIC assay was shown in 
Table 2. It is clear that 24 h treatment for fungal 
suspension with P. harmala is much more effective than 
2 and 6 h treatment. 
 
 
DISCUSSION 
 
P. harmala seeds have been considered from ancient 
time to date as a plant with drug usages regarding to 
some alkaloids compounds such as harmalin and 
harmalol. The compounds extracted from this plant have 
shown different medical characteristics such as anti 
inflammation effects of pitolin were reported by El-Saad 
El Rifaei (1980). He confirmed anti bacterial/anti fungal, 
anti fever and anti parasite effects on P. harmala. Most 
studies on medical effects of P. harmala are on parasite 
infections. Levchenko was one of the first people 
(Levchenko, 1987) who reported the medical effects of 
alkaloids of P. harmala on bovine Theileriosis et al. 
(1994) indicated protoscolocidal effects on P. harmala in 
hydatid  cysts  (Rashan,  1989). Some compounds of this 
plant have anti parasite and anti microbial effects such as 
alkaloids that have drug usage on Babesia infected cattle 
(Fan et al., 1997). Anti bacteria and anti fungal activity of 
harmaline have reported by Abdel-Fattah et al, (1995). 
Most relevant researches are in vivo studies, but they are 
rare in vitro studies such as Shahverdi et al. on anti 
microbial effects of smoking of P. harmala seeds, also 
chemical effects of the plant on Staphylococcus    
epidermidis    and Cryptococcus neoformans (Shahverdi 
et al., 2005).  
The plant on Staphylococcus epidermidis and In this 
study anti fungal activity of P. harmala on 6 and 3 species 
of Candida and Aspergillus, (respectively) was evaluated 
in vitro. The inhibitory activity of alcoholic extract of P. 
harmala has been measured by the determination of MIC 
and MFC parameters. The lowest MIC was shown on 
Candina albicans the highest MIC on C. glabrata. Low 
activity of Peganum extract on C. albicans can be 
explained by the resistance of most of C. albicans clinical 
strains to anti fungal drugs. Shafiee and Gilani tested anti 
fungal activity of P. harmala seeds on Microsporom, 
Trichophyton and Fonescae pedrosoei with serial 
dilutions and they reported 0.125 mg/ml as lowest MIC. In 
the present study MIC differs in different species of 
Candida. MICs  were  decreased  from  0.25 to 0.031 mg/ 
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Figure 2. Modified Morphology of A. flavus in colony coloration and sporolation in the dilutions 0.3 to 0.02. 
 
 
 
Table 2. Effect of incubation time on fungicidal activity of P. harmala extract. 
 
Species No. of isolates Growth after 2 h Growth after 6 h Growth after 24 h 
C. albicans 16 G G NG 
C. parapsilosis             1 NG NG NG 
C. keffyre                        1 NG NG NG 
C. glabrata                    2 G NG NG 
C. tropicalis                  1 NG NG NG 
 
G: growth, NG: no growth. 
 
 
 
ml on Candida species:  C. albicans, to C. tropicalis and 
C. glabrata, respectively. By the consideration of dense 
and compact cell wall of yeasts comparing filamentous 
fungi cell walls, it seems to be reasonable that Candida 
spp. were resistant to P. harmala extract more than 
Aspergillus spp. Although P. harmala alcoholic extract 
inhibited mildly A. niger and A. fumigatus but it was not 
considerable. The alcoholic extract of Iranian P. harmala 
showed inhibitory and fungicidal activities on 
opportunistic pathogenic Candida spp, but it caused very 
low inhibition of growth and sporolation of tested 
Aspergillus spp. 
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